{"transactions":[{"id":2672556,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":138384,"kind":"person","name":"Bonner Michael","position":1,"cik":"0001666790","reported_name":"Bonner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options (right to buy)","published_at":"2021-06-11T21:07:58.000Z","date":"2021-05-17","kind":"disposition_to_issuer","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Resigned position as Chief Financial Officer effective May 17, 2021.  All unvested equity awards forfeited upon resignation."}],"balance_after":0,"derivative":{"exercise_price":3.22,"exercise_date":"2025-03-17","expiration_date":"2031-03-17","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-21-039917","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919121039917/doc4.xml","form_type":"4"}},{"id":2672555,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":138384,"kind":"person","name":"Bonner Michael","position":1,"cik":"0001666790","reported_name":"Bonner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options (right to buy)","published_at":"2021-06-11T21:07:58.000Z","date":"2021-03-17","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"100% vesting on March 17, 2025."}],"balance_after":5000,"derivative":{"exercise_price":3.22,"exercise_date":"2025-03-17","expiration_date":"2031-03-17","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-21-039917","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919121039917/doc4.xml","form_type":"4"}},{"id":2672554,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":138384,"kind":"person","name":"Bonner Michael","position":1,"cik":"0001666790","reported_name":"Bonner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-06-11T21:07:58.000Z","date":"2021-05-17","kind":"other","acquired":false,"shares":7500,"price":2.83,"value":21225.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Resigned position as Chief Financial Officer effective May 17, 2021.  All unvested equity awards forfeited upon resignation."}],"balance_after":11720,"source":{"system":"sec-edgar","filing":"0001209191-21-039917","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919121039917/doc4.xml","form_type":"4"}},{"id":2672553,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":138384,"kind":"person","name":"Bonner Michael","position":1,"cik":"0001666790","reported_name":"Bonner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-06-11T21:07:58.000Z","date":"2021-03-17","kind":"tax_withholding","acquired":false,"shares":1067,"price":3.22,"value":3435.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents shares purchased by the Company to cover the tax withholding obligations for the vesting of shares."}],"balance_after":19220,"source":{"system":"sec-edgar","filing":"0001209191-21-039917","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919121039917/doc4.xml","form_type":"4"}},{"id":3174609,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":138384,"kind":"person","name":"Bonner Michael","position":1,"cik":"0001666790","reported_name":"Bonner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-04-17T21:18:40.000Z","date":"2020-03-23","kind":"grant","acquired":true,"shares":2500,"price":3.56,"value":8900.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Restricted stock award will vest 100% on March 23, 2024."}],"balance_after":20287,"source":{"system":"sec-edgar","filing":"0001209191-20-024880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919120024880/doc4.xml","form_type":"4"}},{"id":3174608,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":138384,"kind":"person","name":"Bonner Michael","position":1,"cik":"0001666790","reported_name":"Bonner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-04-17T21:18:40.000Z","date":"2020-03-18","kind":"tax_withholding","acquired":false,"shares":2134,"price":3.53,"value":7533.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents shares purchased by the Company to cover the tax withholding obligations for the vesting of shares."}],"balance_after":17787,"source":{"system":"sec-edgar","filing":"0001209191-20-024880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919120024880/doc4.xml","form_type":"4"}},{"id":3582003,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":138384,"kind":"person","name":"Bonner Michael","position":1,"cik":"0001666790","reported_name":"Bonner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-03-22T21:23:54.000Z","date":"2019-03-22","kind":"tax_withholding","acquired":true,"shares":1033,"price":5.62,"value":5805.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction represents shares withheld by the Company to cover the tax withholding obligations for the vesting of shares."}],"balance_after":19921,"source":{"system":"sec-edgar","filing":"0001209191-19-021052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119021052/doc4.xml","form_type":"4"}},{"id":3582002,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":138384,"kind":"person","name":"Bonner Michael","position":1,"cik":"0001666790","reported_name":"Bonner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-03-22T21:23:54.000Z","date":"2019-03-22","kind":"grant","acquired":true,"shares":2500,"price":5.98,"value":14950.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock award will vest 100% on March 18, 2023."}],"balance_after":20954,"source":{"system":"sec-edgar","filing":"0001209191-19-021052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119021052/doc4.xml","form_type":"4"}},{"id":3829033,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":138384,"kind":"person","name":"Bonner Michael","position":1,"cik":"0001666790","reported_name":"Bonner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-08-31T21:19:57.000Z","date":"2018-08-29","kind":"purchase","acquired":true,"shares":100,"price":6.24,"value":624.0,"ownership":{"direct":true},"balance_after":18454,"source":{"system":"sec-edgar","filing":"0001209191-18-049112","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919118049112/doc4.xml","form_type":"4"}},{"id":3829032,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":138384,"kind":"person","name":"Bonner Michael","position":1,"cik":"0001666790","reported_name":"Bonner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-08-31T21:19:57.000Z","date":"2018-08-28","kind":"purchase","acquired":true,"shares":300,"price":5.92,"value":1776.0,"ownership":{"direct":true},"balance_after":18354,"source":{"system":"sec-edgar","filing":"0001209191-18-049112","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919118049112/doc4.xml","form_type":"4"}},{"id":3926336,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":138384,"kind":"person","name":"Bonner Michael","position":1,"cik":"0001666790","reported_name":"Bonner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-05-18T21:11:06.000Z","date":"2018-05-17","kind":"purchase","acquired":true,"shares":400,"price":6.12,"value":2448.0,"ownership":{"direct":true},"balance_after":18054,"source":{"system":"sec-edgar","filing":"0001209191-18-031475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919118031475/doc4.xml","form_type":"4"}},{"id":3984178,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":138384,"kind":"person","name":"Bonner Michael","position":1,"cik":"0001666790","reported_name":"Bonner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-23T21:40:55.000Z","date":"2018-03-23","kind":"tax_withholding","acquired":false,"shares":843,"price":6.7,"value":5648.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares."}],"balance_after":17654,"source":{"system":"sec-edgar","filing":"0001209191-18-021463","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919118021463/doc4.xml","form_type":"4"}},{"id":3984177,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":138384,"kind":"person","name":"Bonner Michael","position":1,"cik":"0001666790","reported_name":"Bonner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-23T21:40:55.000Z","date":"2018-03-23","kind":"grant","acquired":true,"shares":2500,"price":6.7,"value":16750.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock award will vest 100% on March 20, 2022."}],"balance_after":18497,"source":{"system":"sec-edgar","filing":"0001209191-18-021463","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919118021463/doc4.xml","form_type":"4"}},{"id":3984176,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":138384,"kind":"person","name":"Bonner Michael","position":1,"cik":"0001666790","reported_name":"Bonner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-23T21:40:55.000Z","date":"2018-03-19","kind":"purchase","acquired":true,"shares":300,"price":6.72,"value":2016.0,"ownership":{"direct":true},"balance_after":15997,"source":{"system":"sec-edgar","filing":"0001209191-18-021463","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919118021463/doc4.xml","form_type":"4"}},{"id":4151850,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":138384,"kind":"person","name":"Bonner Michael","position":1,"cik":"0001666790","reported_name":"Bonner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-11-24T22:15:24.000Z","date":"2017-11-22","kind":"purchase","acquired":true,"shares":250,"price":7.81,"value":1952.5,"ownership":{"direct":true},"balance_after":15697,"source":{"system":"sec-edgar","filing":"0001209191-17-062464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919117062464/doc4.xml","form_type":"4"}},{"id":4224687,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":138384,"kind":"person","name":"Bonner Michael","position":1,"cik":"0001666790","reported_name":"Bonner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-08-25T20:57:59.000Z","date":"2017-08-23","kind":"purchase","acquired":true,"shares":500,"price":6.72,"value":3360.0,"ownership":{"direct":true},"balance_after":15447,"source":{"system":"sec-edgar","filing":"0001209191-17-050310","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919117050310/doc4.xml","form_type":"4"}},{"id":4296521,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":138384,"kind":"person","name":"Bonner Michael","position":1,"cik":"0001666790","reported_name":"Bonner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-06-02T21:21:34.000Z","date":"2017-05-31","kind":"purchase","acquired":true,"shares":300,"price":6.95,"value":2085.0,"ownership":{"direct":true},"balance_after":14947,"source":{"system":"sec-edgar","filing":"0001209191-17-037364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919117037364/doc4.xml","form_type":"4"}},{"id":4356241,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":138384,"kind":"person","name":"Bonner Michael","position":1,"cik":"0001666790","reported_name":"Bonner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-04-07T20:52:21.000Z","date":"2017-04-07","kind":"tax_withholding","acquired":false,"shares":653,"price":6.45,"value":4211.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction represents shares withheld by the Company to cover the tax withholding obligations for the vesting of 2,000 shares during March 2017."}],"balance_after":14647,"source":{"system":"sec-edgar","filing":"0001209191-17-026295","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919117026295/doc4.xml","form_type":"4"}},{"id":4356240,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":138384,"kind":"person","name":"Bonner Michael","position":1,"cik":"0001666790","reported_name":"Bonner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-04-07T20:52:21.000Z","date":"2017-04-07","kind":"grant","acquired":true,"shares":2500,"price":6.45,"value":16125.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock award will vest 100% on March 17, 2021."}],"balance_after":15300,"source":{"system":"sec-edgar","filing":"0001209191-17-026295","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919117026295/doc4.xml","form_type":"4"}},{"id":4373216,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":138384,"kind":"person","name":"Bonner Michael","position":1,"cik":"0001666790","reported_name":"Bonner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-03-24T21:00:50.000Z","date":"2017-03-23","kind":"purchase","acquired":true,"shares":900,"price":6.42,"value":5778.0,"ownership":{"direct":true},"balance_after":12800,"source":{"system":"sec-edgar","filing":"0001209191-17-022787","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919117022787/doc4.xml","form_type":"4"}},{"id":4549140,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":138384,"kind":"person","name":"Bonner Michael","position":1,"cik":"0001666790","reported_name":"Bonner Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2016-11-18T22:13:16.000Z","date":"2016-11-17","kind":"purchase","acquired":true,"shares":900,"price":5.5,"value":4950.0,"ownership":{"direct":true},"balance_after":11900,"source":{"system":"sec-edgar","filing":"0001209191-16-151281","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919116151281/doc4.xml","form_type":"4"}}]}